04/24/2025
7:02 PM | Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
02/04/2025
3:02 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:02 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:50 PM | Panbela Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/19/2024
5:40 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:00 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:01 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:02 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:03 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:04 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for PBLA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/18/2024
4:05 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:00 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:15 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:03 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:06 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:09 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
6:40 PM | Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13D | |
10/29/2024
6:38 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:27 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
4:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:26 PM | Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:25 PM | Panbela Therapeutics (Filer)
| Form S-1/A | |
08/13/2024
7:39 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:40 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:42 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:43 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:45 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:46 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:47 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
How Trade Wars Are Creating Fresh Opportunities for Investors (Ad) Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity.
New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early.
That’s why we’ve just released our latest research:
📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio” Position yourself ahead of the next move—get the full report here. |
07/30/2024
4:30 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
07/30/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:46 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy PBLA Stock Free PBLA Stock Alerts